Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Advising chemo without tissue diagnosis amounts to medical negligence: Commission directs Tata Memorial Hospital, doctor to pay Rs 5L compensation

Farhat Nasim29 May 2023 5:11 PM IST

Mumbai: Noting that without tissue diagnosis advising chemo was the act of omission, the National Consumer Disputes Redressal Commission (NCDRC) has...

Indian Pharma Market registers 11 percent growth in April: IQVIA

Farhat Nasim24 May 2023 11:51 AM IST

New Delhi: The Indian Pharmaceutical Market (IPM) has reported double-digit growth of 11 percent for the month of April 2023, according to IQVIA.On a...

ITAT relief to doctor, quashes addition of Rs 95 lakh allegedly paid as capitation fees for admitting his ward to MD Dermatology course

Farhat Nasim19 May 2023 4:43 PM IST

Mumbai: In a respite to a doctor embroiled in protracted tax litigation, the Income-Tax Appellate Tribunal (ITAT) has quashed the addition of Rs 95...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Immediately suspend use of Magnex, Magnex Forte, Zosyn, Magnamycin: Pfizer warns doctors, chemists against use of 4 antibiotics

Farhat Nasim19 May 2023 2:23 PM IST

New Delhi: Citing an alert on "deviation in manufacturing process", drug major Pfizer has initiated temporary suspension of the sale and use of its...

Delhi HC bars Zydus Wellness from using brand name Sugarlite

Farhat Nasim17 May 2023 6:20 PM IST

Delhi: In a major setback to Zydus Wellness, the Delhi High Court has barred the consumer goods giant from using brand name Sugarlite in any...

JIPMER Dual Degree MBBS-BAMS Programme not yet shelved, Internal Committee to Evaluate Proposal

JIPMER Director, Gynaecologist held liable for negligence in laparoscopy surgery, told to pay Rs 23 lakh compensation

Farhat Nasim16 May 2023 5:17 PM IST

Puducherry: The Director of Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) and a professor of gynaecology at the...

Prices of drugs going off patent to be reduced by 50 percent

Farhat Nasim15 May 2023 7:01 PM IST

New Delhi: The Union Government has decided to slash the ceiling price of the drugs going off patent by 50 percent, and specified that the drug...

Central Govt full stop to doctor-pharma nexus- Curtails MR visits in Govt hospitals

Farhat Nasim15 May 2023 3:07 PM IST

New Delhi: Putting an end to the unholy doctor pharma nexus aimed at unethically promoting and prescribing certain pharma brands, the Union Government...

Merely Displaying MD Cal In Letterhead Is Not Misleading: Commission Absolves MBBS Doctor Of Medical Negligence Charges

Farhat Nasim9 May 2023 6:12 PM IST

New Delhi: The National Consumer Disputes Redressal Commission (NCDRC) has exonerated Kolkata based hospital and its doctors from charges of medical...

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology

Cipla, JB Chemicals dragged to court for alleged infringement of Vifor FCM patent

Farhat Nasim9 May 2023 5:00 PM IST

New Delhi: Cipla Ltd and J B Chemicals and Pharmaceuticals have been embroiled in a court case as Swiss drug firm Vifor International moves Delhi High...

Aurobindo Pharma arm API facility gets 3 observations from USFDA

Aurobindo Pharma Director gets bail in Delhi Excise Policy Case

Farhat Nasim9 May 2023 4:14 PM IST

New Delhi: In a major respite to Aurobindo Pharma director P Sarath Chandra Reddy, the Delhi High Court has granted him bail in connection with the...

Post-Operative Complications cannot be equated to Medical Negligence of Doctor: NCDRC

Issue of Specialist Degrees comes before NCDRC during medical negligence case, Forum gives relief to Gynaecologist, MBBS doctor

Farhat Nasim7 May 2023 5:21 PM IST

New Delhi: Observing that as long as the doctor performs his duties to the best of his ability and with due care and caution, negligence can’t be...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok